| HMS LINCS ID:
|
51095
|
| Name:
|
LY2
|
| Alternative Names:
|
LY 2
|
| LINCS ID:
|
LCL-2076
|
| Alternative ID:
|
CLO_0009913
|
| Parent Cell Line:
|
|
| Reference Source:
|
Mark Lippman (National Cancer Institute)
|
| Organism:
|
Homo sapiens
|
| Organ:
|
breast
|
| Tissue:
|
|
| Cell Type:
|
|
| Details of Cell Type:
|
|
| Donor Sex:
|
|
| Donor Age:
|
|
| Donor Ethnicity:
|
|
| Donor Health Status:
|
|
| Disease:
|
|
| Details of Disease:
|
|
| Production Details:
|
The cell line was selected by increasing the concentration of LY 117018, a potent antiestrogen that inhibits cell growth at concentrations as low as 10(-10) M, in the growth medium in a stepwise manner from 10(-8) to 10(-6) M as the cells become resistant.
|
| Genetic Modification(s):
|
none
|
| Known Mutations:
|
|
| Citation Information for Mutations:
|
|
| Verification Reference Profile:
|
|
| Growth Properties:
|
|
| Recommended Culture Conditions:
|
|
| Relevant Citations:
|
PMID 4029083
|
| Usage Note:
|
|
| Comments:
|
|
| Date Publicly Available:
|
2013-07-30
|
| Most Recent Update:
|
2016-07-12
|